COCRYSTAL PHARMA, INC. (COCP) Operating income 2016–2025
COCRYSTAL PHARMA, INC. (COCP) annual operating income history from SEC filings — each fiscal year as reported.
-$9.0MFY2025 · since FY2016: -$105.8M → -$9.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$9.0M | +49.6% |
| FY2024 | -$17.9M | +3.7% |
| FY2023 | -$18.6M | +52.2% |
| FY2022 | -$38.8M | -173.0% |
| FY2021 | -$14.2M | -48.4% |
| FY2020 | -$9.6M | +80.2% |
| FY2019 | -$48.4M | +23.1% |
| FY2018 | -$62.9M | -661.6% |
| FY2017 | -$8.3M | +92.2% |
| FY2016 | -$105.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More COCP financial trends
COCP RevenueCOCP Net incomeCOCP Net marginCOCP Gross profitCOCP Gross marginCOCP Operating marginCOCP Operating cash flowCOCP Free cash flowCOCP Capital expendituresCOCP Return on equityCOCP Stock buybacksCOCP Dividends paidCOCP Total assetsCOCP Total liabilitiesCOCP Shareholders’ equityCOCP overview →